CONSOLIDATED STATEMENTS OF INCOME (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
REVENUE:
Dental practice revenue	$ 58,461,286		$ 56,513,816		$ 56,952,704
Capitation revenue	5,644,588		5,840,373		6,167,903
Total revenue	64,105,874		62,354,189		63,120,607
DIRECT EXPENSES:
Clinical salaries and benefits	38,171,494		35,402,831		35,647,158
Dental supplies	2,799,518		2,693,604		2,742,398
Laboratory fees	3,108,544		3,133,481		2,863,431
Occupancy	5,822,508		5,549,650		5,390,982
Advertising and marketing	1,082,034		2,018,264		2,666,930
Depreciation and amortization	3,448,707		2,838,582		2,505,957
General and administrative	4,774,597		4,934,926		5,705,741
Total direct expense	59,207,402		56,571,338		57,522,597
Contribution from dental offices	4,898,472		5,782,851		5,598,010
CORPORATE EXPENSES:
General and administrative	4,604,320	[1]	4,207,681	[1]	3,544,074	[1]
Depreciation and amortization	200,431		161,693		122,217
OPERATING INCOME	93,721		1,413,477		1,931,719
OTHER INCOME (EXPENSE):
Change in fair value of contingent liabilities	196,000		0		830,000
Gain from early extinguishment of debt	22,059		0		0
Interest (expense), net	(100,647)		(104,147)		(80,920)
INCOME BEFORE INCOME TAXES	211,133		1,309,330		2,680,799
Income tax expense	121,960		502,066		1,065,472
NET INCOME	$ 89,173		$ 807,264		$ 1,615,327
Net income per share of Common Stock - Basic (in dollars per share)	$ 0.05		$ 0.44		$ 0.87
Net income per share of Common Stock - Diluted (in dollars per share)	$ 0.05		$ 0.44		$ 0.85
Cash dividends per share of Common Stock (in dollars per share)	$ 0.88		$ 0.88		$ 0.86
Weighted average number of shares of Common Stock and dilutive securities:
Basic (in shares)	1,850,257		1,839,149		1,853,307
Diluted (in shares)	1,861,088		1,848,714		1,909,760

[1] Corporate expenses - general and administrative includes $335,076 of stock-based compensation expense pursuant to ASC Topic 718 for the year ended December 31, 2011, $600,936 of stock-based compensation expense pursuant to ASC Topic 718 for the year ended December 31, 2012 and $467,028 of stock-based compensation expense pursuant to ASC Topic 718 for the year ended December 31, 2013.